Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanbing Xue

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Acta Biomaterialia|June 6, 2020
Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapyXu Cheng, Le He, Jiaxi Xu, et al.
Acta Pharmaceutica Sinica. B|December 13, 2021
Self-assembled ternary hybrid nanodrugs for overcoming tumor resistance and metastasisXu Cheng, Dapeng Li, Jiaxi Xu, et al.
Acta Biomaterialia|May 22, 2021
Dynamic precise dual-drug-backboned nano-prodrugs for selective chemotherapyLongshun Yang, Guoqing Yan, Shi Wang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Acta Biomaterialia|June 6, 2020
Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapyXu Cheng, Le He, Jiaxi Xu, et al.
Acta Pharmaceutica Sinica. B|December 13, 2021
Self-assembled ternary hybrid nanodrugs for overcoming tumor resistance and metastasisXu Cheng, Dapeng Li, Jiaxi Xu, et al.
Acta Biomaterialia|May 22, 2021
Dynamic precise dual-drug-backboned nano-prodrugs for selective chemotherapyLongshun Yang, Guoqing Yan, Shi Wang, et al.
Pageof 2